Search by Drug Name or NDC
NDC 47682-0811-48 Medi First Pain Relief 110; 162; 32.4; 152 mg/1; mg/1; mg/1; mg/1 Details
Medi First Pain Relief 110; 162; 32.4; 152 mg/1; mg/1; mg/1; mg/1
Medi First Pain Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Unifirst First Aid Corporation. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE.
Product Information
| NDC | 47682-0811 |
|---|---|
| Product ID | 47682-811_f5633c0d-bcef-b9f6-e053-2a95a90a9353 |
| Associated GPIs | 64990004600304 |
| GCN Sequence Number | 057728 |
| GCN Sequence Number Description | ASA/salicylam/acetaminoph/caff TABLET 162-110MG ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 22939 |
| HICL Sequence Number | 001796 |
| HICL Sequence Number Description | ASPIRIN/SALICYLAMIDE/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Brand |
| Proprietary Name | Medi First Pain Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 110; 162; 32.4; 152 |
| Active Ingredient Units | mg/1; mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE |
| Labeler Name | Unifirst First Aid Corporation |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Listing Certified Through | n/a |
Package
NDC 47682-0811-48 (47682081148)
| NDC Package Code | 47682-811-48 |
|---|---|
| Billing NDC | 47682081148 |
| Package | 125 PACKET in 1 BOX (47682-811-48) / 2 TABLET in 1 PACKET |
| Marketing Start Date | 2008-12-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |